Future Market Insights analysis suggests that the pet joint health supplements market will increasingly shift toward advanced formulations and targeted delivery mechanisms as pet ownership patterns evolve toward preventive healthcare approaches. FMI expects the market to transition from basic glucosamine formulations toward comprehensive joint support systems that integrate multiple active ingredients and specialized delivery formats.